At Intelliject we are committed to closing the gap between the potential of medicines and the benefit realized by putting patients right at the center of product development. The resulting solutions lead to improved health outcomes, as well as better value and increased satisfaction for patients, their carers, healthcare professionals and payers.
We achieve this by combining our suite of breakthrough drug delivery technology with a human factors engineering approach that creates a specific solution tailored to the precise needs of patients and other key stakeholders for a given disease.
Intelliject was founded by patients committed to developing better, more intuitive and convenient solutions for themselves and fellow patients at risk for anaphylaxis. We bring this same passion and commitment to what is right for patients into every disease area in which we operate.
This website is intended solely for entities that are potential commercial partners of Intelliject, Inc. Members of the public, patients and healthcare professionals should not enter this website.
Intelliject currently has no approved products and nothing herein should be considered a promotional claim.
All information contained herein is intended to assist interested parties in assessing possible commercial relationships with Intelliject, Inc. All information is believed to be correct at the date of posting but may change at any time.
